Aspira Pathlab Reports Strong Financial Growth and Operational Achievements in June 2025
Aspira Pathlab & Diagnostics has announced its financial results for the quarter ending June 2025, showcasing significant growth. The company reported a Profit After Tax of Rs 1.10 crore for the six-month period, reflecting a year-on-year increase of 344.44%, alongside net sales of Rs 11.03 crore, up 30.38%.
Aspira Pathlab & Diagnostics has recently reported its financial results for the quarter ending June 2025, revealing notable developments within the healthcare services sector. The company's score has undergone an adjustment, reflecting changes in its evaluation over the past three months.In terms of financial performance, Aspira Pathlab reported a Profit After Tax (PAT) of Rs 1.10 crore for the latest six-month period, which represents a significant year-on-year growth of 344.44%. This positive trend in PAT indicates a strong operational performance during this timeframe. Additionally, net sales reached Rs 11.03 crore, marking a year-on-year increase of 30.38%. This growth in sales suggests a favorable trajectory for the company in the near term.
Furthermore, the PAT for the latest six months has surpassed the preceding twelve-month period, indicating that Aspira Pathlab has already exceeded its previous annual performance within just half a year. These developments highlight the company's current standing in the market and its operational achievements.
For more insights on Aspira Pathlab's performance and evaluation changes, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
